General Information of Drug Off-Target (DOT) (ID: OTGLGK1R)

DOT Name Kv channel-interacting protein 1 (KCNIP1)
Synonyms KChIP1; A-type potassium channel modulatory protein 1; Potassium channel-interacting protein 1; Vesicle APC-binding protein
Gene Name KCNIP1
Related Disease
Atrial fibrillation ( )
Attention deficit hyperactivity disorder ( )
Cervical cancer ( )
Cervical carcinoma ( )
Multiple sclerosis ( )
Non-insulin dependent diabetes ( )
Schizophrenia ( )
Sclerosing cholangitis ( )
Amyotrophic lateral sclerosis ( )
Silver-Russell syndrome ( )
Status epilepticus seizure ( )
Syndromic X-linked intellectual disability Snyder type ( )
UniProt ID
KCIP1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
1S1E; 2I2R; 2NZ0; 7E83; 7E84; 7F3F; 7W6N; 7W6T
Pfam ID
PF13499 ; PF13833
Sequence
MGAVMGTFSSLQTKQRRPSKDIAWWYYQYQRDKIEDELEMTMVCHRPEGLEQLEAQTNFT
KRELQVLYRGFKNECPSGVVNEDTFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFE
DFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKED
TPRQHVDVFFQKMDKNKDGIVTLDEFLESCQEDDNIMRSLQLFQNVM
Function
Regulatory subunit of Kv4/D (Shal)-type voltage-gated rapidly inactivating A-type potassium channels. Regulates channel density, inactivation kinetics and rate of recovery from inactivation in a calcium-dependent and isoform-specific manner. In vitro, modulates KCND1/Kv4.1 and KCND2/Kv4.2 currents. Increases the presence of KCND2 at the cell surface.
Tissue Specificity
Isoform 1 and isoform 2 are expressed in brain and kidney. Isoform 1 is also expressed in liver, pancreas, skeletal muscle, small intestine and testis. Isoform 2 is also expressed in lung, pancreas, leukocytes, prostate and thymus.
Reactome Pathway
Phase 1 - inactivation of fast Na+ channels (R-HSA-5576894 )

Molecular Interaction Atlas (MIA) of This DOT

12 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Atrial fibrillation DIS15W6U Strong Genetic Variation [1]
Attention deficit hyperactivity disorder DISL8MX9 Strong Genetic Variation [2]
Cervical cancer DISFSHPF Strong Biomarker [3]
Cervical carcinoma DIST4S00 Strong Biomarker [3]
Multiple sclerosis DISB2WZI Strong Genetic Variation [4]
Non-insulin dependent diabetes DISK1O5Z Strong Biomarker [5]
Schizophrenia DISSRV2N Strong Genetic Variation [6]
Sclerosing cholangitis DIS7GZNB Strong Genetic Variation [7]
Amyotrophic lateral sclerosis DISF7HVM Limited Genetic Variation [8]
Silver-Russell syndrome DISSVJ1D Limited Biomarker [9]
Status epilepticus seizure DISY3BIC Limited Altered Expression [9]
Syndromic X-linked intellectual disability Snyder type DISN836E Limited Biomarker [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 12 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
8 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Kv channel-interacting protein 1 (KCNIP1). [10]
Triclosan DMZUR4N Approved Triclosan increases the expression of Kv channel-interacting protein 1 (KCNIP1). [11]
Ethinyl estradiol DMODJ40 Approved Ethinyl estradiol decreases the expression of Kv channel-interacting protein 1 (KCNIP1). [12]
AMEP DMFELMQ Phase 1 AMEP increases the expression of Kv channel-interacting protein 1 (KCNIP1). [14]
Bisphenol A DM2ZLD7 Investigative Bisphenol A affects the expression of Kv channel-interacting protein 1 (KCNIP1). [15]
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of Kv channel-interacting protein 1 (KCNIP1). [16]
3R14S-OCHRATOXIN A DM2KEW6 Investigative 3R14S-OCHRATOXIN A increases the expression of Kv channel-interacting protein 1 (KCNIP1). [17]
Glyphosate DM0AFY7 Investigative Glyphosate increases the expression of Kv channel-interacting protein 1 (KCNIP1). [14]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Kv channel-interacting protein 1 (KCNIP1). [13]
------------------------------------------------------------------------------------

References

1 Genome-wide screening identifies a KCNIP1 copy number variant as a genetic predictor for atrial fibrillation.Nat Commun. 2016 Feb 2;7:10190. doi: 10.1038/ncomms10190.
2 Attention-deficit/hyperactivity disorder associated with KChIP1 rs1541665 in Kv channels accessory proteins.PLoS One. 2017 Nov 27;12(11):e0188678. doi: 10.1371/journal.pone.0188678. eCollection 2017.
3 KF-finder: identification of key factors from host-microbial networks in cervical cancer.BMC Syst Biol. 2018 Apr 24;12(Suppl 4):54. doi: 10.1186/s12918-018-0566-x.
4 Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms.Brain Pathol. 2020 Jan;30(1):106-119. doi: 10.1111/bpa.12760. Epub 2019 Jul 23.
5 Divergent patterns of genic copy number variation in KCNIP1 gene reveal risk locus of type 2 diabetes in Chinese population.Endocr J. 2018 May 28;65(5):537-545. doi: 10.1507/endocrj.EJ17-0496. Epub 2018 Feb 27.
6 Genome-wide association study of paliperidone efficacy.Pharmacogenet Genomics. 2017 Jan;27(1):7-18. doi: 10.1097/FPC.0000000000000250.
7 Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.Gut. 2018 Aug;67(8):1517-1524. doi: 10.1136/gutjnl-2016-313598. Epub 2017 Aug 4.
8 Protein aggregation due to nsSNP resulting in P56S VABP protein is associated with amyotrophic lateral sclerosis.J Theor Biol. 2014 Aug 7;354:72-80. doi: 10.1016/j.jtbi.2014.03.027. Epub 2014 Mar 27.
9 Saikosaponin A modulates remodeling of Kv4.2-mediated A-type voltage-gated potassium currents in rat chronic temporal lobe epilepsy.Drug Des Devel Ther. 2018 Sep 11;12:2945-2958. doi: 10.2147/DDDT.S166408. eCollection 2018.
10 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
11 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
12 The genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol. Toxicol Sci. 2009 Jan;107(1):40-55.
13 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
14 Use of human neuroblastoma SH-SY5Y cells to evaluate glyphosate-induced effects on oxidative stress, neuronal development and cell death signaling pathways. Environ Int. 2020 Feb;135:105414. doi: 10.1016/j.envint.2019.105414. Epub 2019 Dec 23.
15 The genomic response of Ishikawa cells to bisphenol A exposure is dose- and time-dependent. Toxicology. 2010 Apr 11;270(2-3):137-49. doi: 10.1016/j.tox.2010.02.008. Epub 2010 Feb 17.
16 Cellular reactions to long-term volatile organic compound (VOC) exposures. Sci Rep. 2016 Dec 1;6:37842. doi: 10.1038/srep37842.
17 Persistence of epigenomic effects after recovery from repeated treatment with two nephrocarcinogens. Front Genet. 2018 Dec 3;9:558.